GlassScriptPhysician profile
Steven R Kessler
NPI 1689611626
$10,277.98
in general payments reported to CMS, 2019-2025
47 companies · $3,290 in 2025
The $3,290 reported for 2025 was more than what 88% of Gastroenterology (Internal Medicine) providers received nationally (typical 2025 total: $636).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,100 · 2020: $268 · 2021: $65.74 · 2022: $1,650 · 2023: $1,684 · 2024: $2,219 · 2025: $3,290.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $6,895 · Travel and Lodging: $256 · Education: $42.64.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $6,894.65 |
| Travel and Lodging | $256.34 |
| Education | $42.64 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $2,223.37 | 2019-2025 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $757.87 | 2019-2025 | Xifaxan, Trulance, Relistor |
| Janssen Biotech, INC. | $675.78 | 2022-2025 | Tremfya, Stelara, Simponi |
| Takeda Pharmaceuticals U.S.A., INC. | $644.56 | 2019-2025 | Entyvio, Eohilia |
| Boston Scientific Corporation | $594.83 | 2022-2025 | Overstitch Endoscopic Suturing System, Overstitch Nxt Endoscopic Suturing System, Axios |
| Regeneron Healthcare Solutions, INC. | $464.09 | 2022-2025 | Dupixent |
| Celgene Corporation | $384.27 | 2022-2024 | Zeposia |
| Gilead Sciences, INC. | $365.93 | 2019-2025 | Livdelzi |
| Endogastric Solutions, INC | $274.68 | 2022-2024 | Esophyx |
| Olympus America INC. | $256.27 | 2019 | |
| Pfizer INC. | $255.06 | 2019-2025 | |
| Lilly USA, LLC | $249.72 | 2022-2025 | Omvoh |
| Merck Sharp & Dohme LLC | $249.03 | 2019-2024 | Dificid |
| Celltrion USA INC. | $226.11 | 2024-2025 | Vegzelma, Zymfentra |
| Madrigal Pharmaceuticals | $216.64 | 2025 | Rezdiffra |
Show all 46 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Ferring Pharmaceuticals INC. | $214.93 | 2019-2023 | Rebyota |
| Ironwood Pharmaceuticals, INC | $194.30 | 2019-2024 | |
| E.R. Squibb & Sons, L.L.C. | $178.03 | 2022-2023 | |
| Aimmune Therapeutics, INC. | $174.10 | 2024-2025 | Zenpep |
| Genzyme Corporation | $152.47 | 2023-2025 | |
| Ucb, INC. | $137.83 | 2019-2020 | |
| Redhill Biopharma INC. | $132.61 | 2022-2023 | Talicia, Aemcolo, Movantik |
| 3-D Matrix, INC. | $124.78 | 2024 | |
| Cerapedics INC. | $116.36 | 2024 | I-Factor Peptide Enhanced Bone Graft |
| Phathom Pharmaceuticals, INC. | $115.77 | 2023-2025 | Voquezna |
| Intercept Pharmaceuticals, INC. | $113.80 | 2019-2025 | |
| Janssen Scientific Affairs, LLC | $113.19 | 2022 | |
| Daiichi Sankyo INC. | $82.99 | 2019-2024 | Injectafer |
| Medtronic, INC. | $79.38 | 2021-2025 | Endoflip |
| Conmed Corporation | $70.33 | 2025 | Conmed Biliary, Conmed Hemostasis |
| Merit Medical Systems INC | $67.56 | 2025 | Endomaxx Stent and Delivery System, Esophyx |
| Braintree Laboratories, INC. | $53.26 | 2019-2023 | Sutab |
| Evoke Pharma, INC. | $40.66 | 2023-2024 | Gimoti |
| Ardelyx, INC. | $35.21 | 2023 | Ibsrela |
| Mallinckrodt Hospital Products INC. | $33.96 | 2023 | Terlivaz |
| Qol Medical, LLC | $28.61 | 2019-2021 | |
| Mauna Kea Technologies, INC. | $24.08 | 2025 | |
| Philips North America LLC | $21.26 | 2019 | |
| Nestle Healthcare Nutrition INC. | $20.83 | 2022 | |
| Exact Sciences Corporation | $20.35 | 2023 | Cologuard Collection Kit |
| Ambu INC. | $19.49 | 2023 | |
| Orphalan INC | $19.26 | 2025 | Cuvrior |
| Dentsply Ih Ab | $18.35 | 2024 | Navina Rectal Catheter Set Regular |
| Ipsen Biopharmaceuticals, INC | $16.65 | 2024 | Bylvay |
| Fresenius Kabi USA, LLC | $13.84 | 2023 | Idacio |
| Echosens North America, INC. | $5.53 | 2025 | Fibroscan |
1 company reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Steven Kessler listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.